Unlearn.AI Company

Unlearn.AI develops a platform to accelerate clinical trials for Alzheimer's Disease, Multiple Sclerosis, and other complex diseases.
Technology: AI, Clinical Trials
Industry: Clinical Development
Headquarters: San Francisco, California, United States
Founded Date: 01.01.2017
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 3
Total Funding: $15 M
Estimated Revenue: $1M to $10M
Last Funding Type: Series A

Visit Website
partnerships@unlearn.ai
https://twitter.com/unlearnai
Register and Claim Ownership